Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4H949
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.496 |
CLV_PCSK_KEX2_1 | 104 | 106 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.548 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.569 |
CLV_PCSK_PC1ET2_1 | 38 | 40 | PF00082 | 0.548 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.569 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.739 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.514 |
DOC_USP7_UBL2_3 | 25 | 29 | PF12436 | 0.688 |
DOC_USP7_UBL2_3 | 63 | 67 | PF12436 | 0.708 |
DOC_USP7_UBL2_3 | 90 | 94 | PF12436 | 0.524 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.618 |
LIG_14-3-3_CanoR_1 | 45 | 52 | PF00244 | 0.679 |
LIG_14-3-3_CanoR_1 | 7 | 13 | PF00244 | 0.706 |
LIG_BRCT_BRCA1_1 | 74 | 78 | PF00533 | 0.657 |
LIG_LIR_Gen_1 | 75 | 82 | PF02991 | 0.659 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.634 |
LIG_SH2_STAP1 | 107 | 111 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.410 |
LIG_SUMO_SIM_anti_2 | 11 | 16 | PF11976 | 0.744 |
MOD_CDK_SPK_2 | 24 | 29 | PF00069 | 0.618 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.665 |
MOD_Cter_Amidation | 23 | 26 | PF01082 | 0.704 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.544 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.633 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.539 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.563 |
MOD_PIKK_1 | 62 | 68 | PF00454 | 0.543 |
MOD_PKA_1 | 105 | 111 | PF00069 | 0.415 |
MOD_PKA_2 | 105 | 111 | PF00069 | 0.522 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.557 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.421 |
MOD_PKB_1 | 39 | 47 | PF00069 | 0.597 |
MOD_Plk_1 | 52 | 58 | PF00069 | 0.566 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.616 |
TRG_ER_diArg_1 | 103 | 106 | PF00400 | 0.548 |
TRG_ER_diArg_1 | 39 | 42 | PF00400 | 0.479 |
TRG_NLS_Bipartite_1 | 25 | 42 | PF00514 | 0.655 |
TRG_NLS_MonoExtC_3 | 36 | 41 | PF00514 | 0.648 |
TRG_NLS_MonoExtN_4 | 35 | 42 | PF00514 | 0.570 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KMF1 | Bodo saltans | 46% | 83% |
A0A1X0NKS3 | Trypanosomatidae | 57% | 98% |
A0A3Q8IAX0 | Leishmania donovani | 82% | 100% |
A4HXG3 | Leishmania infantum | 82% | 100% |
C9ZNE7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 93% |
E9AR58 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4QEA5 | Leishmania major | 85% | 99% |